228 related articles for article (PubMed ID: 36510206)
21. Is multifocality a risk factor in low-risk papillary thyroid cancer?
Sapuppo G; Grasso S; Di Benedetto G; Marturano I; Costanzo G; Belfiore A; Pellegriti G
Endokrynol Pol; 2022; 73(6):928-934. PubMed ID: 36094871
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of microwave ablation for the treatment of multifocal versus unifocal T1N0M0 papillary thyroid carcinoma: a propensity-matched multicentre retrospective study.
Zhao ZL; Dong G; Wang SR; Liu Y; He JF; Shi LL; Guo JQ; Wang ZH; Cong ZB; Liu LH; Yang BB; Qu CP; Wei Y; Peng LL; Li Y; Lu NC; Wu J; Yu MA
Eur Radiol; 2023 Dec; 33(12):8727-8735. PubMed ID: 37466709
[TBL] [Abstract][Full Text] [Related]
23. The appropriateness of thyroid lobectomy as an initial surgery for preoperatively detected unilateral multifocal papillary carcinoma.
Albinsaad LS; Kim WW; Lee YM; Sung TY; Chung KW; Hong SJ
Asian J Surg; 2021 Aug; 44(8):1050-1055. PubMed ID: 33573922
[TBL] [Abstract][Full Text] [Related]
24. Number of tumor foci predicts prognosis in papillary thyroid cancer.
Qu N; Zhang L; Ji QH; Zhu YX; Wang ZY; Shen Q; Wang Y; Li DS
BMC Cancer; 2014 Dec; 14():914. PubMed ID: 25471041
[TBL] [Abstract][Full Text] [Related]
25. Bilaterality, not multifocality, is an independent risk factor for recurrence in low-risk papillary thyroid cancer.
Rodriguez Schaap PM; Lin JF; Metman MJH; Dreijerink KMA; Links TP; Bonjer HJ; Nieveen van Dijkum EJM; Dickhoff C; Kruijff S; Engelsman AF
J Natl Cancer Inst; 2023 Sep; 115(9):1071-1076. PubMed ID: 37267155
[TBL] [Abstract][Full Text] [Related]
26. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer?
Elbasan O; Ilgın C; Gogas Yavuz D
Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491
[TBL] [Abstract][Full Text] [Related]
27. Risk Factors for Central Neck Lymph Node Metastases in Micro- Versus Macro- Clinically Node Negative Papillary Thyroid Carcinoma.
Sessa L; Lombardi CP; De Crea C; Tempera SE; Bellantone R; Raffaelli M
World J Surg; 2018 Mar; 42(3):623-629. PubMed ID: 29238850
[TBL] [Abstract][Full Text] [Related]
28. A UK based two-centre review of multifocality and its role in the treatment of papillary thyroid cancer.
Li LQ; Hey SY; Andreeva D; Tornari C; Sawant R; Harding NE; Adamson R; Hay A; Simo R; Nixon IJ
Eur J Surg Oncol; 2022 Jan; 48(1):14-20. PubMed ID: 34253424
[TBL] [Abstract][Full Text] [Related]
29. Trends of the prevalence rate of central lymph node metastasis and multifocality in patients with low-risk papillary thyroid carcinoma after delayed thyroid surgery.
Wang P; Dong Z; Zhao S; Su Y; Zhang J; Ma Y; Diao C; Qian J; Cheng R; Liu W
Front Endocrinol (Lausanne); 2024; 15():1349272. PubMed ID: 38638135
[TBL] [Abstract][Full Text] [Related]
30. Clinical features of multifocal papillary thyroid carcinoma and risk factors of cervical metastatic lymph nodes.
Ni Y; Wang T; Wang X; Tian Y; Wei W; Liu Q
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):225-232. PubMed ID: 36161301
[TBL] [Abstract][Full Text] [Related]
31. Multifocality Is not an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score-Matching Analysis.
Geron Y; Benbassat C; Shteinshneider M; Or K; Markus E; Hirsch D; Levy S; Ziv-Baran T; Muallem-Kalmovich L
Thyroid; 2019 Apr; 29(4):513-522. PubMed ID: 30799769
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Risk Factors Contributing to Recurrence of Papillary Thyroid Carcinoma in Chinese Patients Who Underwent Total Thyroidectomy.
Zhang W; Jiao D; Liu B; Sun S
Med Sci Monit; 2016 Apr; 22():1274-9. PubMed ID: 27084873
[TBL] [Abstract][Full Text] [Related]
33. Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence.
Choi WR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Jul; 94():106-110. PubMed ID: 31178204
[TBL] [Abstract][Full Text] [Related]
34. Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma.
Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH
Head Neck; 2015 May; 37(5):650-4. PubMed ID: 24590814
[TBL] [Abstract][Full Text] [Related]
35. A quantitative assessment of the number of disease foci in papillary thyroid cancer.
Evans Harding N; Simo R; Li L; Maniam P; Adamson R; Hay A; Conn B; Lyall M; Nixon IJ
Eur J Surg Oncol; 2023 Jul; 49(7):1141-1146. PubMed ID: 37024371
[TBL] [Abstract][Full Text] [Related]
36. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
37. Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma?
Scholfield DW; Lopez J; Eagan A; Antal Z; Tuttle RM; Ghossein R; LaQuaglia M; Shaha AR; Shah JP; Wong RJ; Patel SG; Ganly I
J Clin Endocrinol Metab; 2023 Nov; 108(12):3135-3144. PubMed ID: 37350510
[TBL] [Abstract][Full Text] [Related]
38. Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment?
Calò PG; Pisano G; Medas F; Marcialis J; Gordini L; Erdas E; Nicolosi A
World J Surg Oncol; 2014 May; 12():152. PubMed ID: 24885654
[TBL] [Abstract][Full Text] [Related]
39. Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis.
Heng Y; Yang Z; Lin J; Liu Q; Cai W; Tao L
Oral Oncol; 2022 Nov; 134():106185. PubMed ID: 36191477
[TBL] [Abstract][Full Text] [Related]
40. Total thyroidectomy versus unilateral lobectomy for unilateral multifocal papillary thyroid carcinoma: systematic review and meta‑analysis.
Chen H; Liu Y; Huang D; Zhang X; She L
Updates Surg; 2024 Jan; 76(1):33-41. PubMed ID: 38127193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]